Canada Wants More Agility And Alignment In Drug Regulations
Executive Summary
The Canadian regulator has proposed several changes to current drug regulations to deliver on its modernization commitments and leverage long-standing policies and practices.
You may also be interested in...
Canada Addresses Diversity In Clinical Trials With New Rule For Drug Filings
Health Canada wants drug sponsors to start answering questions relating to disaggregated data for sex, age and race.
New Canadian Rule Allows Rolling Data Submissions For COVID-19 Drugs, Vaccines
The Canadian authorities have put in place an expedited pathway for authorizing new COVID-19 drugs and vaccines that offers a more agile approach to reviewing data than what was previously allowed.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.